Marshall Goldsmith

NOVEMBER 4, 2013

” Their ideal leader is a person who develops “win-win” relationships and is sensitive to their needs for personal growth and development. Leaders will need to develop skills in negotiation and “win-win” relationships. In return, they feel a responsibility to deliver value back.

Short-term 107

Short-term Long-term Trends Telecommunications 107

Harvard Business Review

AUGUST 3, 2016

We know that mergers and acquisitions are challenging for the companies involved. Regulators try to model how prices, sales, and even the combining parties’ research and development efforts will change after a merger. On the one hand, M&As can help companies use their resources more efficiently.

Innovation 8

Innovation Pharmaceuticals Company Price 8

Marshall Goldsmith

FEBRUARY 8, 2018

14th Administrator, United States Agency for International Development. US News and World Report #1 Best Hospital in the United States – Fortune ‘100 Best Companies to Work For,’ 14 consecutive years. Garry Ridge – CEO, WD-40 Company. a holding company that operates seven distinct business. Healthcare Leaders.

Executive Coaching 70

Executive Coaching CEO Magazine Banking 70

Strategy Driven

JULY 13, 2011

Performance measurement typically drives much of the way a large company works. Supplementing profits with ROIC and revenue growth is a step in the right direction to ensure that the profits a business earns are actually creating value, not simply over-consuming capital that another company could better deploy.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Harvard Business Review

SEPTEMBER 12, 2012

The study assembles considerable evidence about the hidden business model of major pharmaceutical companies: to devote most of their research budget to developing hundreds of drugs that provide few if any advantages over existing drugs and then market them heavily to doctors and patients.

Business Model 15

Business Model Company Pharmaceuticals Price 15

Harvard Business Review

JULY 8, 2016

They’ve simply undercut Western competitors by offering cheaper prices. Entrepreneurs in Chinese industries from animated media to applied medical research said that China’s insistence on domestic standards are resulting in less-ambitious innovation and that the education system is not supporting appropriate talent development.

Business Model 13

Business Model Innovation Company Apparel 13

Harvard Business Review

MARCH 14, 2017

When one of us (Vivek) and his team launched Roivant Sciences in 2014 and began developing treatments for Alzheimer’s disease — they were determined to learn from the pharma industry’s innovation issues and build a more sustainable innovation engine. Food and Drug Administration (FDA), the lowest number since 2007.

Innovation 13

Innovation Company Incentives Industry 13

Harvard Business Review

MARCH 12, 2012

But in today's interdependent world, this flawed belief is proving a thorn in the balloon that would otherwise raise many companies' future commercial success. Indeed, the true paradox that smart, trailblazing companies are solving is how to outperform their competition by collaborating with their competition. His blunt response: No.

Co-Opetition 14

Co-Opetition Company Brandenburger Game Theory 14

Harvard Business Review

AUGUST 17, 2012

Most of its sales are in the developing world (including 40% in Africa) — where it sells its HIV drugs for about $350 per year per patient — yet it is as profitable as the pharma giants of Europe, North America, and Japan. and other traditionally developed markets. and other traditionally developed markets.

Company 11

Company Pharmaceuticals Business Model Fixed Costs 11

Harvard Business Review

JUNE 7, 2012

On Fast Company's website, Bruce Kasanoff and Michael Hinshaw offer a nifty little primer for prospective disruptors. Each industry has practices that drive customers crazy," write the authors of Smart Customers, Stupid Companies. Is there something companies in your industry do that's just as stupid? Looking for more?

Disruptive Innovation 22

Disruptive Innovation Innovation Pharmaceuticals Class 22

Harvard Business Review

MARCH 27, 2018

Facebook, at that time, allowed app developers to collect this personal data. Facebook, Google, Amazon, and similar companies are “data-opolies.” The velocity in acquiring and exploiting this personal data can help these companies obtain significant market power. That influence comes in part from data. In the U.S.,

Company 14

Company Advertising Incentives Engineering 14

Harvard Business Review

APRIL 22, 2015

Since the late nineteenth century, we have seen five distinct movements in the way companies compete. Many companies still compete this way and there continue to be successors to Taylorism, including business process reengineering and lean production. Edwards Deming , who introduced quality as a way of life for Japanese companies.

Six Sigma 8

Six Sigma Company Lean Production Taylorism 8

Harvard Business Review

MAY 26, 2016

While a dynamic, competitive economy rewards innovative firms with high profits and punishes poor performers with low profits, sustained aggregate profits suggest, instead, that firms are able to get away with higher prices because competition is limited. Even when regulators try to reduce prices, firms can benefit.

Pharmaceuticals 14

Pharmaceuticals Politics Price Chemicals 14

Strategy Driven

MARCH 18, 2011

The conventional wisdom about strategy may be leading your company astray. Achieving coherence requires a sharpness of focus that few companies have mastered. In this unpredictable economy, traditional approaches to strategy are a luxury most companies cannot afford. by Paul Leinwand and Cesare Mainardi. Let’s go after it.”

Resources 51

Resources Industry System Strategy 51

Harvard Business Review

AUGUST 9, 2012

Selling pharmaceuticals in Latin America is not the same as selling them in the United States or Western Europe. So if a doctor prescribes a medication priced at 100 pesos, that is what it will cost the patient. So if a doctor prescribes a medication priced at 100 pesos, that is what it will cost the patient.

Pharmaceuticals 14

Pharmaceuticals Strategy Advertising Price 14

Harvard Business Review

DECEMBER 20, 2011

Throughout its history, Pfizer's biggest product and the biggest-selling branded drug in pharmaceutical industry history, has delivered some confounding strategic lessons. Diplomat will sell mail-order branded Lipitor at generic prices. And both teach lessons that apply across many industries. Lipitor's Long Good-bye.

Disintermediation 16

Disintermediation Industry Pharmaceuticals Price 16

Harvard Business Review

JUNE 7, 2012

On Fast Company's website, Bruce Kasanoff and Michael Hinshaw offer a nifty little primer for prospective disruptors. Each industry has practices that drive customers crazy," write the authors of Smart Customers, Stupid Companies. Is there something companies in your industry do that's just as stupid? Looking for more?

Disruptive Innovation 12

Disruptive Innovation Innovation Pharmaceuticals Class 12

Harvard Business Review

APRIL 2, 2018

There is an abundance of high-quality comparative effectiveness data for pharmaceuticals, largely because of the drug approval process, but there’s less data on the value of other expensive investments into health, such as doctor visits and hospitalizations. (For

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

JANUARY 31, 2013

First we see major shifts in demand: developing economies such as China and India are morphing from the world's source of low-cost manufacturing capacity to the world's best market opportunities. They will not, it must be noted, alter how the role of manufacturing evolves as economies develop.

Globalization 11

Globalization Supply Chain Pharmaceuticals McKinsey 11

Harvard Business Review

SEPTEMBER 22, 2015

As the ire over high prescription drug prices in the United States escalates , it’s easy to blame pharmaceutical companies. But pharmaceutical companies aren’t to blame. But blaming them for their high prices is short-sighted finger pointing. virtually every country regulates prices and the U.S.

Pharmaceuticals 8

Pharmaceuticals Price Budgeting Insurance 8

Harvard Business Review

APRIL 4, 2018

Take United Airlines CEO Oscar Munoz, whose initial response to the violent removal of a fare-paying passenger from one of the company’s planes led to a public backlash. Or the notorious case of Martin Shkreli, the former CEO of Turing Pharmaceuticals, who failed to apologize for dramatically raising the price of a life-saving drug.

Creativity 15

Creativity Pharmaceuticals Learning-by-Doing Team 15

Harvard Business Review

NOVEMBER 1, 2017

million adults in the United States with high blood sugar levels in danger of developing type 2 diabetes. The company worked collaboratively with the CDC and was one the first three digital DPP providers that the agency recognized for meeting its evidence-based standards. In addition there are 84.1

Health Care 15

Health Care Participative Wireless Pharmaceuticals 15

Harvard Business Review

MAY 5, 2016

Foreign companies, foreign governments, and Iranians expected to see improvements to Iran’s investment climate after implementing a nuclear deal and sanctions relief in the country. This slow pace of change has left many senior leaders at multinational companies frustrated and doubtful about Iran’s potential. For non-U.S.-based

Tourism 8

Tourism Banking Due Diligence Hotels 8

Harvard Business Review

SEPTEMBER 5, 2016

The UK’s Department for International Development uses “results-based” aid to improve the educational outcomes of young girls in Africa and Asia. Cigna is the first insurance company to get pharmaceutical companies to agree to value pricing based on results for certain cholesterol-lowering drugs.

Incentives 8

Incentives Health Care Education Insurance 8

Harvard Business Review

SEPTEMBER 14, 2017

Most companies pay salespeople a combination of a salary, a commission, and a bonus for hitting a quota, putting a portion of their pay at risk. Within an industry or company, pay mix often varies across sales roles. Free sales come in two forms. Franchise sales have nothing to do with salespeople.

Motivation 8

Motivation Incentives Franchising Short-term 8

Harvard Business Review

NOVEMBER 8, 2017

The health care system in the United States, with its technological prowess and massive infrastructure, often serves as a reference point for rapidly developing economies around the world while they build their own medical systems. Over the same period, pharmaceutical exports have doubled. Victor Albrow/Getty Images.

Health Care 8

Health Care Tourism Pharmaceuticals Cost 8

Harvard Business Review

MAY 17, 2012

Each year, twenty million babies worldwide are born prematurely or with a low birth weight, and four million of them die, most in developing nations. Unfortunately, current options for warming babies in developing nations are either expensive or unsafe. That insight led them to fundamentally rethink who their users really were.

Incubator 12

Incubator Business Model Entrepreneur Cost 12

Harvard Business Review

MARCH 2, 2011

The days when you could make a living responding to companies' discovery of strategy, as in "Gosh, we gotta get ourselves one of those," are gone with the 1970s (or maybe the 1990s in the "developing world"). Strategy has triumphed, the installed base is huge, no self-respecting company would be without one.

Consultative 16

Consultative Strategy McKinsey Porter 16

Harvard Business Review

DECEMBER 14, 2017

To be the change that many desire, these new mergers and acquisitions, and the others that will likely follow, must produce a higher-quality product for consumers (and satisfy physicians and other health professionals) at an affordable price. The answer is far from certain, and the uncertainties differ for the two mergers.

Health Care 8

Health Care System Insurance Pharmaceuticals 8

Harvard Business Review

MAY 7, 2015

A company is only as valuable as its customers and to gain or keep them, you have to do a specific job for them. “It’s a measure of how much value an individual customer, or customer segment, gets from using a company’s products or services,” says Avery. What is EVC? ” How do you calculate EVC?

Price 8

Price Venture Capitalist Incentives Cost 8

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. Merck and Co.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

APRIL 19, 2016

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. Executive teams need to assess their industries’ and companies’ time horizons for the technology, because they will have a huge amount of strategic and business process planning to do before their companies adopt it.

Supply Chain 8

Supply Chain Execution Analysis Technology 8

Harvard Business Review

JANUARY 5, 2018

For example, in 2009 professors Brian Becker, Mark Huselid, and Richard Beatty estimated that in most companies less than 15% of jobs are what they call strategic positions and said management should focus “disproportionate investments” on finding A players for those jobs. Connectors in the middle. Customer experience creators.

McKinsey 8

McKinsey Human Resources Reputation Brand 8

Harvard Business Review

OCTOBER 26, 2011

The net result is that many VCs now turn down promising companies that might contribute to transforming the way we produce energy. Despite these gloomy headlines, three developments in the sector give us hope that the revolution in clean energy production is far from dead: 1.

Energy 11

Energy Finance IPO Biotechnology 11

Harvard Business Review

JUNE 16, 2016

Yet, in the first quarter of 2016 the company sold only $17 million of Entresto in the U.S. by both insurance companies and cardiologists to a new and expensive drug (which costs more than $4,000 a year, compared to pennies a day for existing drugs). The failure stemmed from resistance in the U.S. Study personal use of intelligence.

Planning 8

Planning Competitive Intelligence Pharmaceuticals Brand 8

Harvard Business Review

SEPTEMBER 7, 2015

First, there has never been a greater need for companies to learn new ways of doing things in response to a complex and dynamic business environment. And coaching or mentoring approaches have great merits for personal development, but are hard to scale. Live pilots are highly realistic but costly, time consuming and risky.

Seminar 8

Seminar Learning Curve Strategy Comparison 8

Harvard Business Review

FEBRUARY 14, 2014

In the shadow of MIT, there are dozens of large biotech and life sciences companies, and many dozens of startups. Because of Kendall Square’s concentration of talent, and its infrastructure, Novartis, the giant Swiss pharmaceutical company, moved nearly its entire research center here from Switzerland. As it develops, the U.S.

Chemicals 8

Chemicals Pharmaceuticals Energy Creativity 8